SpyGlass Pharma, Inc. (SGP) cash on hand

Cash · fiscal 2025
$107.44M

SpyGlass Pharma, Inc. (SGP) held cash of $107.44M at the end of fiscal 2025 (December 31, 2025). That is 560.4% higher than the $16.27M of fiscal 2024. Figures as of 18 Nov 2026, 01:23 UTC, from Yahoo Finance.

Key facts

Cash, fiscal 2025
$107.44M
Change on fiscal 2024
+560.4%
Highest on record
$107.44Mfiscal 2025
Lowest on record
$16.27Mfiscal 2024
Fiscal years on record
32023–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

SpyGlass Pharma, Inc. cash on hand, in more detail

Across the 3 fiscal years on record (2023–2025), the highest was $107.44M in fiscal 2025 and the lowest $16.27M in fiscal 2024.

History · 3 fiscal years

Cash by fiscal year

SpyGlass Pharma, Inc. cash on hand, year by year

SpyGlass Pharma, Inc. (SGP) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$107.44M 560.4% up
2024$16.27M 59.6% down
2023$40.32M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

More on SGP

SpyGlass Pharma, Inc., figure by figure

SpyGlass Pharma, Inc. (SGP) overview: price, valuation and scorecard

SpyGlass Pharma, Inc. cash on hand: questions and answers

How much cash does SpyGlass Pharma, Inc. have?

SpyGlass Pharma, Inc. (SGP) held cash of $107.44M at the end of fiscal 2025 (December 31, 2025). That is 560.4% higher than the $16.27M of fiscal 2024.

What are the highest and lowest cash figures on record for SpyGlass Pharma, Inc.?

Across the 3 fiscal years on record (2023–2025), the highest was $107.44M in fiscal 2025 and the lowest $16.27M in fiscal 2024.

How is SpyGlass Pharma, Inc.'s cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “SpyGlass Pharma, Inc. (SGP) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/SGP/cash

Underlying data: Yahoo Finance.